269 related articles for article (PubMed ID: 20709760)
1. CAV1 inhibits metastatic potential in melanomas through suppression of the integrin/Src/FAK signaling pathway.
Trimmer C; Whitaker-Menezes D; Bonuccelli G; Milliman JN; Daumer KM; Aplin AE; Pestell RG; Sotgia F; Lisanti MP; Capozza F
Cancer Res; 2010 Oct; 70(19):7489-99. PubMed ID: 20709760
[TBL] [Abstract][Full Text] [Related]
2. Src-family kinase inhibitors block early steps of caveolin-1-enhanced lung metastasis by melanoma cells.
Ortiz R; Díaz J; Díaz-Valdivia N; Martínez S; Simón L; Contreras P; Lobos-González L; Guerrero S; Leyton L; Quest AFG
Biochem Pharmacol; 2020 Jul; 177():113941. PubMed ID: 32240650
[TBL] [Abstract][Full Text] [Related]
3. E-cadherin determines Caveolin-1 tumor suppression or metastasis enhancing function in melanoma cells.
Lobos-González L; Aguilar L; Diaz J; Diaz N; Urra H; Torres VA; Silva V; Fitzpatrick C; Lladser A; Hoek KS; Leyton L; Quest AF
Pigment Cell Melanoma Res; 2013 Jul; 26(4):555-70. PubMed ID: 23470013
[TBL] [Abstract][Full Text] [Related]
4. Caveolin-1 is a risk factor for postsurgery metastasis in preclinical melanoma models.
Lobos-Gonzalez L; Aguilar-Guzmán L; Fernandez JG; Muñoz N; Hossain M; Bieneck S; Silva V; Burzio V; Sviderskaya EV; Bennett DC; Leyton L; Quest AF
Melanoma Res; 2014 Apr; 24(2):108-19. PubMed ID: 24500501
[TBL] [Abstract][Full Text] [Related]
5. Genetic ablation of Cav1 differentially affects melanoma tumor growth and metastasis in mice: role of Cav1 in Shh heterotypic signaling and transendothelial migration.
Capozza F; Trimmer C; Castello-Cros R; Katiyar S; Whitaker-Menezes D; Follenzi A; Crosariol M; Llaverias G; Sotgia F; Pestell RG; Lisanti MP
Cancer Res; 2012 May; 72(9):2262-74. PubMed ID: 22396494
[TBL] [Abstract][Full Text] [Related]
6. FAK regulates E-cadherin expression via p-SrcY416/p-ERK1/2/p-Stat3Y705 and PPARγ/miR-125b/Stat3 signaling pathway in B16F10 melanoma cells.
Pei G; Lan Y; Chen D; Ji L; Hua ZC
Oncotarget; 2017 Feb; 8(8):13898-13908. PubMed ID: 28108732
[TBL] [Abstract][Full Text] [Related]
7. Extracellular matrix-specific Caveolin-1 phosphorylation on tyrosine 14 is linked to augmented melanoma metastasis but not tumorigenesis.
Ortiz R; Díaz J; Díaz N; Lobos-Gonzalez L; Cárdenas A; Contreras P; Díaz MI; Otte E; Cooper-White J; Torres V; Leyton L; Quest AF
Oncotarget; 2016 Jun; 7(26):40571-40593. PubMed ID: 27259249
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of glycolysis and Src/Akt signaling reduces Caveolin-1-enhanced metastasis.
Simón L; Torres K; Contreras P; Díaz-Valdivia N; Leyton L; Quest AFG
Biomed Pharmacother; 2024 Jul; 176():116841. PubMed ID: 38834004
[TBL] [Abstract][Full Text] [Related]
9. The interaction between caveolin-1 and Rho-GTPases promotes metastasis by controlling the expression of alpha5-integrin and the activation of Src, Ras and Erk.
Arpaia E; Blaser H; Quintela-Fandino M; Duncan G; Leong HS; Ablack A; Nambiar SC; Lind EF; Silvester J; Fleming CK; Rufini A; Tusche MW; Brüstle A; Ohashi PS; Lewis JD; Mak TW
Oncogene; 2012 Feb; 31(7):884-96. PubMed ID: 21765460
[TBL] [Abstract][Full Text] [Related]
10. Galangin inhibits tumor growth and metastasis of B16F10 melanoma.
Zhang W; Tang B; Huang Q; Hua Z
J Cell Biochem; 2013 Jan; 114(1):152-61. PubMed ID: 22887049
[TBL] [Abstract][Full Text] [Related]
11. Deacetylated GM3 promotes uPAR-associated membrane molecular complex to activate p38 MAPK in metastatic melanoma.
Yan Q; Bach DQ; Gatla N; Sun P; Liu JW; Lu JY; Paller AS; Wang XQ
Mol Cancer Res; 2013 Jun; 11(6):665-75. PubMed ID: 23525268
[TBL] [Abstract][Full Text] [Related]
12. The non-receptor tyrosine phosphatase type 14 blocks caveolin-1-enhanced cancer cell metastasis.
Díaz-Valdivia NI; Díaz J; Contreras P; Campos A; Rojas-Celis V; Burgos-Ravanal RA; Lobos-González L; Torres VA; Perez VI; Frei B; Leyton L; Quest AFG
Oncogene; 2020 Apr; 39(18):3693-3709. PubMed ID: 32152405
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 Exposure Disrupts E-Cadherin/Caveolin-1-Mediated Tumor Suppression to Favor Caveolin-1-Enhanced Migration, Invasion, and Metastasis in Melanoma Models.
Lobos-González L; Oróstica L; Díaz-Valdivia N; Rojas-Celis V; Campos A; Duran-Jara E; Farfán N; Leyton L; Quest AFG
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069269
[TBL] [Abstract][Full Text] [Related]
14. Enhancement role of host 12/15-lipoxygenase in melanoma progression.
Kang KH; Ling TY; Liou HH; Huang YK; Hour MJ; Liou HC; Fu WM
Eur J Cancer; 2013 Aug; 49(12):2747-59. PubMed ID: 23664097
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-Induced Caveolin-1 Expression Promotes Migration and Invasion of Tumor Cells.
Castillo Bennett J; Silva P; Martinez S; Torres VA; Quest AFG
Curr Mol Med; 2018; 18(4):199-206. PubMed ID: 30259813
[TBL] [Abstract][Full Text] [Related]
16. Human melanoma cells express FGFR/Src/Rho signaling that entails an adhesion-independent caveolin-1 membrane association.
Fecchi K; Travaglione S; Spadaro F; Quattrini A; Parolini I; Piccaro G; Raggi C; Fabbri A; Felicetti F; Carè A; Fiorentini C; Sargiacomo M
Int J Cancer; 2012 Mar; 130(6):1273-83. PubMed ID: 21445970
[TBL] [Abstract][Full Text] [Related]
17. Integrin alphavbeta3 mediates K1735 murine melanoma cell motility in vivo and in vitro.
Li X; Regezi J; Ross FP; Blystone S; Ilić D; Leong SP; Ramos DM
J Cell Sci; 2001 Jul; 114(Pt 14):2665-72. PubMed ID: 11683393
[TBL] [Abstract][Full Text] [Related]
18. Phosphorylated caveolin-1 regulates Rho/ROCK-dependent focal adhesion dynamics and tumor cell migration and invasion.
Joshi B; Strugnell SS; Goetz JG; Kojic LD; Cox ME; Griffith OL; Chan SK; Jones SJ; Leung SP; Masoudi H; Leung S; Wiseman SM; Nabi IR
Cancer Res; 2008 Oct; 68(20):8210-20. PubMed ID: 18922892
[TBL] [Abstract][Full Text] [Related]
19. CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.
Liu H; Ong SE; Badu-Nkansah K; Schindler J; White FM; Hynes RO
Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1379-84. PubMed ID: 21220330
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticles as tracking devices to shed light on the role of caveolin-1 in early stages of melanoma metastasis.
Guerrero S; Díaz-García VM; Contreras-Orellana P; Lara P; Palma S; Guzman F; Lobos-Gonzalez L; Cárdenas A; Rojas-Silva X; Muñoz L; Leyton L; Kogan MJ; Quest AF
Nanomedicine (Lond); 2018 Jun; 13(12):1447-1462. PubMed ID: 29972676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
